CL2018001936A1 - Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación. - Google Patents

Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.

Info

Publication number
CL2018001936A1
CL2018001936A1 CL2018001936A CL2018001936A CL2018001936A1 CL 2018001936 A1 CL2018001936 A1 CL 2018001936A1 CL 2018001936 A CL2018001936 A CL 2018001936A CL 2018001936 A CL2018001936 A CL 2018001936A CL 2018001936 A1 CL2018001936 A1 CL 2018001936A1
Authority
CL
Chile
Prior art keywords
inflammation
compositions
treatment
bacterial strain
lactobacillus plantarum
Prior art date
Application number
CL2018001936A
Other languages
English (en)
Inventor
Jörg Thilo Fischer
Marcus Rudolf Götz
Göran Molin
Siv Ahrne
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of CL2018001936A1 publication Critical patent/CL2018001936A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA NUEVA CEPA BACTERIANA, L PLANTARUM GOS 42 (DSM 32131), PREPARACIONES AISLADAS Y COMPOSICIONES DE LAS MISMAS; Y SU USO EN MEDICINA, ESPECIALMENTE EN EL TRATAMIENTO Y / O PREVENCIÓN DE LA INFLAMACIÓN.
CL2018001936A 2016-01-19 2018-07-17 Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación. CL2018001936A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1600975.5A GB201600975D0 (en) 2016-01-19 2016-01-19 Novel strain of probiotic bacteria and compositions and uses thereof

Publications (1)

Publication Number Publication Date
CL2018001936A1 true CL2018001936A1 (es) 2019-08-02

Family

ID=55488176

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018001936A CL2018001936A1 (es) 2016-01-19 2018-07-17 Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.

Country Status (22)

Country Link
US (1) US10893695B2 (es)
EP (1) EP3405263B1 (es)
JP (1) JP6899400B2 (es)
KR (1) KR20180101491A (es)
CN (1) CN108738308B (es)
AU (1) AU2017209867B2 (es)
BR (1) BR112018014654B1 (es)
CA (1) CA3011322C (es)
CL (1) CL2018001936A1 (es)
DK (1) DK3405263T3 (es)
ES (1) ES2875765T3 (es)
GB (1) GB201600975D0 (es)
MX (1) MX2018008857A (es)
MY (1) MY193248A (es)
PH (1) PH12018550110A1 (es)
PL (1) PL3405263T3 (es)
PT (1) PT3405263T (es)
RS (1) RS61954B1 (es)
RU (1) RU2729420C2 (es)
SG (1) SG11201806057QA (es)
WO (1) WO2017125446A1 (es)
ZA (1) ZA201804863B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069556B (zh) * 2016-01-19 2022-11-25 西姆莱斯有限公司 用作口腔内抗炎剂的益生菌
WO2019242839A1 (en) * 2018-06-18 2019-12-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
WO2020067170A1 (ja) * 2018-09-25 2020-04-02 国立研究開発法人国立循環器病研究センター 抗腫瘍効果増強剤
CN111996137B (zh) * 2020-08-07 2022-08-05 华东理工大学 一株植物乳杆菌
CN113234639B (zh) * 2021-06-16 2022-08-30 广东海天创新技术有限公司 一株植物乳杆菌zf632及其应用
US20230131140A1 (en) * 2021-10-26 2023-04-27 University Of South Florida Human origin probiotic lactobacilius rhamnosus hl-200 to reduce leaky gut by metabolizing ethanolamine
CN114672480A (zh) * 2022-04-29 2022-06-28 浙江工商大学 植物乳杆菌凝胶珠及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
PL347029A1 (en) 1998-10-01 2002-03-11 Probi Ab Reduction of oxidative stress factors
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
US20040101495A1 (en) 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
SE527555C2 (sv) 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
PT1951272T (pt) 2005-10-06 2016-09-20 Probi Ab Uso de lactobacillus para o tratamento de infeções virais
WO2007140613A1 (en) 2006-06-06 2007-12-13 Mcgill University Fermented milk product and use thereof
BRPI0809454A2 (pt) 2007-03-27 2014-09-09 Procter & Gamble Métodos e kits para a administração de probióticos
AU2009271287A1 (en) 2008-06-24 2010-01-21 Wm. Wrigley Jr. Company Probiotic chewing gum method of manufacture
JP5504485B2 (ja) * 2008-12-04 2014-05-28 国立大学法人広島大学 Ｉｌ−８阻害剤およびその製造方法
EP2379091A2 (en) 2008-12-16 2011-10-26 Nestec S.A. Compositions and methods for improved oral health
JP5337535B2 (ja) * 2009-03-02 2013-11-06 日本ルナ株式会社 Ｎｋ活性増強剤
US20120064118A1 (en) 2009-03-05 2012-03-15 Probiotical S.P.A. Bacteria strains having a high anti-inflammatory activity
DE202009011379U1 (de) * 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
EP2420580A1 (en) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
CA2833937C (en) 2011-05-16 2022-04-05 Organobalance Medical Ag Lactobacillus strains, compositions containing them and use of the strains to prevent or treat conditions caused by streptococcus pyogenes
JP5904028B2 (ja) * 2012-06-19 2016-04-13 ライオン株式会社 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
RU2492851C1 (ru) * 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
CN105007926A (zh) * 2013-03-14 2015-10-28 雀巢产品技术援助有限公司 植物乳杆菌ncc 2936制剂和口腔健康
US9587284B2 (en) 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US9399048B2 (en) 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation

Also Published As

Publication number Publication date
BR112018014654B1 (pt) 2022-06-28
WO2017125446A1 (en) 2017-07-27
PT3405263T (pt) 2021-06-14
PH12018550110A1 (en) 2019-03-18
BR112018014654A2 (pt) 2018-12-11
RU2018129759A (ru) 2020-02-20
JP6899400B2 (ja) 2021-07-07
RU2018129759A3 (es) 2020-03-26
RS61954B1 (sr) 2021-07-30
EP3405263B1 (en) 2021-03-10
MY193248A (en) 2022-09-28
DK3405263T3 (en) 2021-05-17
MX2018008857A (es) 2019-03-06
ES2875765T3 (es) 2021-11-11
PL3405263T3 (pl) 2021-09-20
SG11201806057QA (en) 2018-08-30
CA3011322C (en) 2023-06-27
EP3405263A1 (en) 2018-11-28
KR20180101491A (ko) 2018-09-12
AU2017209867B2 (en) 2022-01-20
GB201600975D0 (en) 2016-03-02
US10893695B2 (en) 2021-01-19
CN108738308B (zh) 2021-04-30
US20190037902A1 (en) 2019-02-07
ZA201804863B (en) 2022-03-30
AU2017209867A1 (en) 2018-08-09
CA3011322A1 (en) 2017-07-27
JP2019506181A (ja) 2019-03-07
RU2729420C2 (ru) 2020-08-06
CN108738308A (zh) 2018-11-02

Similar Documents

Publication Publication Date Title
CL2018001936A1 (es) Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
PE20190432A1 (es) Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis
MX2018000870A (es) Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa.
AU2015286721B2 (en) Influenza virus vaccines and uses thereof
PE20190417A1 (es) Uso de probioticos en el tratamiento y/o la prevencion de la dermatitis atopica
MX2016014564A (es) Vacuna contra la acinetobacter baumannii obtenida a partir de componentes celulares carentes de lipopolisacarido.
IT201600091033A1 (it) Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
MX2018008645A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina
WO2018132696A3 (en) Stomach acid-stable and mucin-binding protein-polymer conjugates
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
BR112018070518A2 (pt) bactéria do gênero bifidobacterium, usos de uma bactéria do gênero bifidobacterium e método para reduzir a ingestão de alimentos, energia e/ou gordura
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
MX2022004570A (es) Vacunas contra el virus de la gripe y usos de estas.
MX2020001501A (es) Streptococcus australis como bioterapeuticos.
CO2020009424A2 (es) Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas
CL2019001938A1 (es) Composiciones probióticas y usos de las mismas.
AR109026A1 (es) Composiciones que comprenden cepas bacterianas
MX2020013860A (es) Composiciones probioticas y sus usos.
AR104992A1 (es) Composiciones comprendiendo cepas bacterianas
EA201992649A1 (ru) Композиции, содержащие бактериальные штаммы